LeMaitre Vascular, Inc. - Medical Equipment - Deals and Alliances Profile -Aarkstore Enterprise

LeMaitre Vascular, Inc. - Medical Equipment - DealsDistribution Agreement With Endologix For
and Alliances Profile is an essential source forPowerlink System
company data and information. The profileJul 29, 2009: LeMaitre Vascular Reports Net Sales
examines the company's key business structureOf $12.6 Million In Q2 2009
and operations, history and products, and providesScope
summary analysis of its key revenue lines and- Provides key company information for business
strategy as well as highlighting the company'sintelligence needs
major recent financial deals.- Gives information on the company's major
LeMaitre Vascular, Inc. (LeMaitre Vascular) is arecent financial deals including mergers &
medical device company principally engaged in theacquisitions, asset transactions, PE/VC deals,
development, manufacture, marketing and sale ofequity offerings, debt offerings and partnerships.
devices that are used in the treatment of- Data is supplemented with details on the
peripheral vascular diseases. The company alsocompany's history, key executives, business
develops and markets disposable and implantabledescription, locations and subsidiaries as well as a
vascular devices. LeMaitre Vascular principallylist of products and services and the latest
operates in the US, Canada, European Union andavailable company statement.
Japan. The company holds about eight subsidiaries.Reasons to buy
It is headquartered in Massachusetts, the US.- A quick "one-stop-shop" to understand the
Recently, in March 2009, LeMaitre Vascularcompany.
completed the termination of distribution- Support sales activities by understanding your
agreement with Edwards Lifesciences, for thecustomers' businesses.
distribution of its AlboGraft Vascular Graft.- Qualify prospective partners and suppliers.
And More inside the report…- Understand and respond to your competitors'
business structure, strategy and prospects
Recent Developmentsthrough.
Oct 28, 2009: LeMaitre Reports Net Sales Of- Understanding the key deals which have shaped
$13.3 Million In Q3 2009the company.
Aug 11, 2009: LeMaitre Vascular Extends Its